Results 81 to 90 of about 16,366 (136)

Comparative Efficacy of High-Dose Daptomycin Monotherapy versus Combination Therapy for Daptomycin-Resistant <i>Enterococcus faecium</i> Endocarditis in a Rat Model. [PDF]

Infect Drug Resist
Yang CJ, Wang JT, Yang JL, Chuang YC.
europepmc   +1 more source

Successful Treatment of Lactobacillus rhamnosus Endocarditis With Intravenous Daptomycin: A Case Report and Literature Review. [PDF]

Case Rep Infect Dis
Rehan MA, Bagwell JT, Wachter SB, Jubbal SS.   +3 more
europepmc   +1 more source

Preclinical and clinical evaluation of vancomycin plus delpazolid combination therapy for MRSA bacteremia: a multicenter, double-blinded, randomized, parallel design, phase IIa clinical trial. [PDF]

Microbiol Spectr
Park K-H, Jung J, Shin SU, Jeong SJ, Park DW, Kim D-M, Choi SJ, Moon SM, Park JS, Song K-H, Kim ES, Cho YL, Bae S, Kim HB, Korea INfectious Diseases (KIND) Study Group.   +14 more
europepmc   +1 more source

Comprehensive pharmacokinetic/pharmacodynamic analysis of commercially available premixed daptomycin preparations against <i>Staphylococcus aureus</i> and <i>Enterococcus</i> spp. bloodstream infections using Monte Carlo simulation in adult patients. [PDF]

JAC Antimicrob Resist
Jaime E, Yassin A, Patel RH, Bhowmick T, Farkas A.   +4 more
europepmc   +1 more source

Emergence of Dalbavancin, Vancomycin, and Daptomycin Cross-resistance in MRSA During Long-term LVAD Suppression With Vancomycin Followed by Dalbavancin: Genomic Insights and Synergy With Cefadroxil. [PDF]

Open Forum Infect Dis
Stohs EJ, Alexander BT, Fey PD, Foreman MCL, Xu L, Penewit K, Waalkes A, Salipante SJ, Werth BJ.   +8 more
europepmc   +1 more source

cGAS/STING sensing in dendritic cells discriminates between daptomycin sensitive and resistant <i>Staphylococcus aureus</i> clinical isolates. [PDF]

iScience
Patton T, Jahan N, Jiang JH, Kostoulias X, Pang ES, Lundie RJ, Balka K, Venkatraman R, Oorschot V, Clark J, Askary S, Tan P, Shoppee A, Ramm G, Peleg AY, De Nardo D, O'Keeffe M.   +16 more
europepmc   +1 more source

<i>In vitro</i> activity of MRS-2541, a novel MetRS inhibitor, against a selection of resistant gram-positive organisms associated with serious hospital infections. [PDF]

Microbiol Spectr
Domagala J, Jahanbakhsh S, Mendez AK, Pillar CM, Marra A, Hufnagel DA, Molasky NMR, Zhang Z, Fan E, Reyna D, Lipka E, Buckner FS.   +11 more
europepmc   +1 more source

Drug-induced eosinophilic pneumonia: a real-world data mining study of the FAERS and Vigibase database reveals potential safety signals and risk patterns. [PDF]

Front Med (Lausanne)
Hu J, Sun Y, Cheng C, Wang S, Zuo X, Liu Y.   +5 more
europepmc   +1 more source